Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
about
Congenital platelet disorders and understanding of platelet function.αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.Glanzmann thrombasthenia: state of the art and future directions.Genetic sequence analysis of inherited bleeding diseases.Genetic dissection of quantitative trait Loci for hemostasis and thrombosis on mouse chromosomes 11 and 5 using congenic and subcongenic strains.Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.Integrin αIIbβ3: from discovery to efficacious therapeutic targetAutosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.Epistaxis as a Common Presenting Symptom of Glanzmann's Thrombasthenia, a Rare Qualitative Platelet Disorder: Illustrative Case ExamplesDeep Vein Thrombosis, Raynaud's Phenomenon, and Prinzmetal Angina in a Patient with Glanzmann Thrombasthenia.Two novel ITGA2B mutations in a Glanzmann thrombasthaenia family associated with different platelet phenotypic expressionLessons from recurrent deep vein thrombosis in Glanzmann thrombasthenia.Challenges on the diagnostic approach of inherited platelet function disorders: Is a paradigm change necessary?
P2860
Q33411778-2FED3546-F1F5-444A-B86F-3405642133E9Q33421611-FB28AE25-70BE-466F-91F5-791B29497283Q33571529-F05F94E2-A75A-47F9-B94B-D62AD7BDC699Q34663589-DE49C8EF-96E2-4B7B-B279-D0C7EC80414FQ35023208-0A9CBB61-8464-4F52-A649-87FAC0454EF5Q35043549-14DAF62C-7B94-455E-800E-5DA7ED1C3158Q37011736-4AD7E980-24BF-479E-8684-F6C729897DCEQ37740966-810C8BB1-A4F4-4AF5-A051-22ECBADE02F4Q38267207-C94E375E-22C9-47DD-9122-3F0D59D10DE4Q38859457-D3D847A3-80D1-4EC5-8778-9B14D70C4171Q39181193-24288A59-865A-4F85-99E6-1173556DCB1DQ42238777-6D90795D-3673-4320-A428-B9F161B01D3EQ42355405-8BD5E6CD-3C0C-4986-B329-35B35D8FF0E1Q45856266-7A892338-3F77-45BE-8DDE-946B63E21E43Q52448095-C7543A4A-9E3C-49C2-A371-3953DF9FA280
P2860
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
@en
type
label
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
@en
prefLabel
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
@en
P2093
P2860
P356
P1476
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
@en
P2093
Alan T Nurden
Paquita Nurden
Xavier Pillois
P2860
P304
P356
10.1586/EHM.12.46
P577
2012-10-01T00:00:00Z